Opus Genetics (IRD) Assets Average (2011 - 2026)

Opus Genetics (IRD) has 16 years of Assets Average data on file, last reported at $58.5 million in Q1 2026.

• On a quarterly basis, Assets Average rose 37.64% year-over-year to $58.5 million in Q1 2026; TTM through Mar 2026 was $58.5 million, a 37.64% increase from a year earlier, with the FY2025 full-year figure at $43.6 million, down 4.08% from the prior year.
• Assets Average for Q1 2026 stood at $58.5 million, up from $43.2 million in the prior quarter.
• Over the last five years, Assets Average for IRD reached as high as $58.5 million in Q1 2026 and fell as low as $16.2 million in Q3 2022.
• Historically, Assets Average has averaged $40.7 million across 5 years, with a median of $43.2 million in 2025.
• Across the five-year window, Assets Average slumped 33.0% in 2022 and jumped 200.79% in 2023, its largest moves.
• Year by year, Assets Average stood at $31.8 million in 2022, then jumped by 70.14% to $54.1 million in 2023, then decreased by 28.56% to $38.6 million in 2024, then advanced by 11.8% to $43.2 million in 2025, then jumped by 35.51% to $58.5 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $58.5 million in Q1 2026, $43.2 million in Q4 2025, and $37.4 million in Q3 2025.